Binding of drugs to hepatic microsomes: Comment and assessment of current prediction methodology with recommendation for improvement

被引：142

作者：

Hallifax, D ^{[1
]}

Houston, JB ^{[1
]}

机构：

[1] Univ Manchester, Sch Pharm & Pharm Sci, Ctr Appl Pharmacokinet Res, Manchester M13 9PL, Lancs, England

来源：

DRUG METABOLISM AND DISPOSITION | 2006年 / 34卷 / 04期

关键词：

D O I：

10.1124/dmd.105.007658

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：724 / 726

页数：3

共 9 条

[1] The binding of drugs to hepatocytes and its relationship to physicochemical properties [J].

Austin, RP ;

Barton, P ;

Mohmed, S ;

Riley, RJ .

DRUG METABOLISM AND DISPOSITION, 2005, 33 (03) :419-425

[2] The influence of nonspecific microsomal binding on apparent intrinsic clearance, and its prediction from physicochemical properties [J].

Austin, RP ;

Barton, P ;

Cockroft, SL ;

Wenlock, MC ;

Riley, RJ .

DRUG METABOLISM AND DISPOSITION, 2002, 30 (12) :1497-1503

[3] The conduct of in vitro and in vivo drug-drug interaction studies: A Pharmaceutical Research and Manufacturers of America (PhRMA) perspective [J].

Bjornsson, TD ;

Callaghan, JT ;

Einolf, HJ ;

Fischer, V ;

Gan, L ;

Grimm, S ;

Kao, J ;

King, SP ;

Miwa, G ;

Ni, L ;

Kumar, G ;

McLeod, J ;

Obach, RS ;

Roberts, S ;

Roe, A ;

Shah, A ;

Snikeris, F ;

Sullivan, JT ;

Tweedie, D ;

Vega, JM ;

Walsh, J ;

Wrighton, SA .

DRUG METABOLISM AND DISPOSITION, 2003, 31 (07) :815-832

[4] Quantitative prediction of the in vivo inhibition of diazepam metabolism by omeprazole using rat liver microsomes and hepatocytes [J].

Jones, HM ;

Hallifax, D ;

Houston, JB .

DRUG METABOLISM AND DISPOSITION, 2004, 32 (05) :572-580

[5]

Naritomi Y, 2001, DRUG METAB DISPOS, V29, P1316

[6]

Obach RS, 1999, DRUG METAB DISPOS, V27, P1350

[7] A unified model for predicting human hepatic, metabolic clearance from in vitro intrinsic clearance data in hepatocytes and microsomes [J].

Riley, RJ ;

McGinnity, DF ;

Austin, RP .

DRUG METABOLISM AND DISPOSITION, 2005, 33 (09) :1304-1311

[8] In vitro analysis of human drug glucuronidation and prediction of in vivo metabolic clearance [J].

Soars, MG ;

Burchell, B ;

Riley, RJ .

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 301 (01) :382-390

[9]

Tucker Geoffrey T., 2001, Clinical Pharmacology and Therapeutics, V70, P103, DOI 10.1067/mcp.2001.116891

← 1 →